Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-2,514
Closed -$218K 278
2019
Q4
$218K Hold
2,514
0.01% 233
2019
Q3
$202K Hold
2,514
0.01% 237
2019
Q2
$201K Buy
+2,514
New +$192K 0.01% 237
2015
Q2
Sell
-12,529
Closed -$717K 358
2015
Q1
$717K Buy
12,529
+7,672
+158% +$434K 0.04% 265
2014
Q4
$263K Buy
4,857
+597
+14% +$33.3K 0.01% 308
2014
Q3
$241K Sell
4,260
-1,488
-26% -$83.6K 0.01% 315
2014
Q2
$317K Buy
5,748
+281
+5% +$15.3K 0.02% 311
2014
Q1
$296K Sell
5,467
-1,585
-22% -$82.1K 0.02% 317
2013
Q4
$337K Sell
7,052
-522
-7% -$23.9K 0.02% 303
2013
Q3
$344K Sell
7,574
-2,120
-22% -$96.8K 0.02% 304
2013
Q2
$430K Buy
+9,694
New +$433K 0.03% 278

Other funds holding MRK

Emerald Advisers's MRK Position: Q1 2020 in Review

Emerald Advisers sold out of Merck (MRK) in Q1 2020, closing a stake of 2,514 shares — an estimated $218K sold.

Emerald Advisers first reported a position in MRK in Q2 2013 and held it in 11 quarters. The position peaked at $717K in Q1 2015. 2,477 funds tracked by Wall St. Rank hold MRK as of Q1 2020.

  • Emerald Advisers reported no remaining Merck position as of Q1 2020 after selling out during the quarter.
  • Emerald Advisers sold 2,514 Merck shares in Q1 2020, an estimated $218K.
  • Emerald Advisers first reported a position in Merck in Q2 2013 and held it in 11 quarters.
  • Emerald Advisers's Merck position peaked at $717K in Q1 2015.
  • 2,477 funds tracked by Wall St. Rank held Merck as of Q1 2020.

Based on Emerald Advisers's 13F filing for Q1 2020, filed 30 Apr 2020.